Internal Medicine, Hematology & Oncology · Sherman Oaks, CA
NPI
1134302409
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4940 Van Nuys Blvd Ste 207
Sherman Oaks, CA, 91403
Phone (818) 616-3998
Groups this clinician bills Medicare through
Medicare paid, 2024
$613K
52,377 services
Medicare patients, 2024
410
Average age 75
Drug cost, 2024
$4.0M
771 prescriptions
Company payments, 2025
$1,149
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sujie Tang was code J0897 (injection, denosumab, 1 mg), 5,340 times for 19 patients. In total Sujie Tang billed 52,377 services in 71 codes, and Medicare paid $613K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,340 | 19 | $5.24 | $28K |
| J0612 Injection, calcium gluconate, not otherwise specified, 10 mg | Office | 2,500 | 12 | $0.03 | $82.63 |
| 99233 Hospital E&M - Subsequent | Facility | 1,333 | 222 | $97.23 | $130K |
| 99215 Office E&M - Established | Office | 847 | 213 | $124.33 | $105K |
| 99214 Office E&M - Established | Office | 673 | 127 | $99.26 | $67K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 600 | 12 | $0.09 | $54.42 |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 530 | 11 | $1.71 | $908 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 450 | 12 | $0.69 | $310 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 330 | 24 | $0.64 | $212 |
| 99223 Hospital E&M - Initial | Facility | 288 | 236 | $140.19 | $40K |
| 99232 Hospital E&M - Subsequent | Facility | 276 | 81 | $64.87 | $18K |
| 96367 Intravenous Infusion, Hydration | Office | 226 | 30 | $25.49 | $5,760 |
| 96365 Intravenous Infusion, Hydration | Office | 186 | 35 | $56.01 | $10K |
| 96413 Chemotherapy Administration | Office | 156 | 24 | $116.12 | $18K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 136 | 12 | $4.83 | $656 |
By year: 2022 $767K for 73,978 services; 2023 $638K for 54,768 services; 2024 $613K for 52,377 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 35 | 14 | $8.65 | $303 |
Medicare prescription drug claims, 2024
In 2024, the drug Sujie Tang prescribed most often to Medicare patients was Xgeva (Denosumab), with 43 prescriptions and refills. In total Sujie Tang wrote 771 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xgeva Denosumab | 43 | 43 | Under 11 | $134K |
| Dexamethasone Generic | 38 | 38 | 12 | $236 |
| Ondansetron Hcl Generic | 30 | 30 | 13 | $429 |
| Ibrance Palbociclib | 29 | 29 | Under 11 | $447K |
| Anastrozole Generic | 27 | 49 | Under 11 | $331 |
| Jakafi Ruxolitinib Phosphate | 24 | 24 | Under 11 | $411K |
| Brukinsa Zanubrutinib | 23 | 23 | Under 11 | $321K |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 23 | 23 | Under 11 | $69K |
| Imbruvica Ibrutinib | 19 | 19 | Under 11 | $304K |
| Tecentriq Atezolizumab | 19 | 19 | Under 11 | $201K |
| Olanzapine Generic | 19 | 19 | Under 11 | $60.07 |
| Hydroxyurea Generic | 18 | 18 | Under 11 | $242 |
| Eliquis Apixaban | 18 | 18 | Under 11 | $9,161 |
| Enhertu Fam-Trastuzumab Deruxtecn-Nxki | 16 | 16 | Under 11 | $181K |
| Erbitux Cetuximab | 16 | 16 | Under 11 | $98K |
Brand drugs: 423 claims; generic drugs: 348 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sujie Tang $1,149 ($1,149 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $136.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $136 |
| Astellas Pharma US Inc 4503.T | 4 | $107 |
| Seagen Inc. PFE | 1 | $99.99 |
| Genentech USA, Inc. ROG.SW | 4 | $99.1 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $96.38 |
| Janssen Biotech, Inc. JNJ | 3 | $72.86 |
| Daiichi Sankyo Inc. 4568.T | 3 | $67.8 |
| Abbvie Inc. ABBV | 3 | $66.57 |
| Lilly USA, LLC LLY | 2 | $62.15 |
| Taiho Oncology, Inc. 4578.T | 2 | $55.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.